Patents by Inventor Karl-Heinz Glüsenkamp

Karl-Heinz Glüsenkamp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis of phosphoric esters
    Patent number: 8940907
    Abstract: The present invention relates to a process for the preparation of phosphoric esters, and to selected compounds.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: January 27, 2015
    Assignee: Merck Patent GmbH
    Inventor: Karl Heinz Gluesenkamp
  • SYNTHESIS OF PHOSPHORIC ESTERS
    Publication number: 20120215006
    Abstract: The present invention relates to a process for the preparation of phosphoric esters, and to selected compounds.
    Type: Application
    Filed: October 8, 2010
    Publication date: August 23, 2012
    Applicant: MERCK PATENTS GESSELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventor: Karl Heinz Gluesenkamp
  • Method for the production of monoalkylamino ketones
    Patent number: 7579484
    Abstract: The invention relates to monoalkylaminoketones of the formula (I), in which R1 and R2 have the meanings indicated.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: August 25, 2009
    Assignee: Merck Patent GmbH
    Inventors: Kai Fabian, Claus-Peter Niesert, Joachim Kralik, Karl-Heinz Glüsenkamp
  • Method for immobilizing biomolecules and affinity ligands on polymer carriers
    Patent number: 6602692
    Abstract: In a method for immobilizing biomolecules and affinity ligands water insoluble matrices, having amino groups and selected from test tubes, microtiter plates, microscope slides, beads, membranes, resins, and filters, are reacted with a cyclobutene carboxylic acid derivative, such as cyclobutene carboxylic acid diester, cyclobutene carboxylic acid halide, cyclobutene carboxylic acid ester halide, cyclobutene carboxylic acid dialkoxyester, and cyclobutene carboxylic acid imidazole, as an activating compound in methanol and triethylamine to form active matrices with active groups. A protein containing at least one primary or secondary amino group, is dissolved and added to the matrices. The activated matrices and the dissolved protein are incubated at pH of 7-10 and a temperature of +4° C. to +60° C. in an aqueous buffer system, free of primary and secondary amines, to thereby immobilize the protein on the matrices.
    Type: Grant
    Filed: June 6, 1996
    Date of Patent: August 5, 2003
    Inventors: Karl-Heinz Glüsenkamp, Gertrud Eberle-Adamkiewics